GlaxoSmithKline May Buy Stake in Dr. Reddy's

UK-based pharma giant GlaxoSmithKline (GSK) is in talks to pick up a 5% stake in Hyderabad-based Dr Reddy's Laboratories (DRL) Pharma in order to strengthen its association with the Indian firm with whom it had signed a marketing alliance four months ago.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.